Status:
COMPLETED
Effect of ORI-guided Oxygen Titration on Oxidative Stress in Rhinoplasty Surgery
Lead Sponsor:
Dr. Lutfi Kirdar Kartal Training and Research Hospital
Conditions:
Rhinoplasty
Oxidative Stress
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to evaluate whether the use of Oxygen Reserve Index (ORİ) can prevent hyperoxia in patients undergoing rhinoplasty surgery and whether it can reduce oxidative stress caused by...
Detailed Description
ORI is a continuous, non-invasive parameter provided by new-generation pulse oximeters utilizing multi-wavelength pulse oximetry technology. ORI serves as an important monitoring tool for detecting bo...
Eligibility Criteria
Inclusion
- classified as ASA physical status I or II
Exclusion
- under 18 years of age
- ASA classification greater than II
- Mallampati score of 3 or 4
- findings suggestive of difficult intubation during physical examination
- any pathological findings on chest X-ray evaluation (e.g., pleural effusion, nodular density increase, emphysema, atelectasis, calcification, mediastinal widening, or infiltration)
- a history of circulatory disorders
- hematocrit or hemoglobin values outside the normal range (Hemoglobin: 12-16 g/dL for males, 11-14 g/dL for females; Hematocrit: 36-48% for males, 33-42% for females)
- a known hypersensitivity to any anesthetic agent to be used in the study.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT07158073
Start Date
March 1 2021
End Date
August 30 2021
Last Update
September 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kartal Dr. Lütfi Kırdar City Hospital
Istanbul, kartal, Turkey (Türkiye), 34862